Stem cells and neurodegenerative diseases

Antonella Consiglio

POSTDOCTORAL RESEARCHERS
  • Valentina Baruffi
  • Eugenia Martínez Hernández
  • Meritxell Pons Espinal
  • Aurora Scrivo
  • Veronica Testa
PREDOCTORAL RESEARCHERS
  • Jara Montero Muñoz
  • Neus Otero Fornes
  • Styliani Stavroulaki
SCIENTIFIC SUPPORT
  • Irene Fernandez Carasa
  • David Piñol Belenguer
  • Esperanza Rodríguez López
MANAGEMENT SUPPORT
  • Ana Martos Guillamet
  • Laia Pages Rigola
VISITING RESEARCHERS
  • Gloria Carrossa
STUDENTS
  • Monica Belles Fernandez
Neuroscience
Neuroscience

Scientific production

3

PAPER

Average IF: 14,70

1

LED PAPER

Average IF: 5,10

3 PUBLICATIONS IN FIRST DECILE

3 PUBLICATIONS IN FIRST QUARTILE

2 PUBLICATIONS IN OPEN ACCESS

Selected publications

  • Khawaja,RR;Martín Segura,A;Santiago Fernández,O;Sereda,R;Lindenau,K;McCabe,M;Macho González,A et al, Sex-specific and cell-type-specific changes in chaperone-mediated autophagy across tissues during aging., Nat Aging, 2025;5(4):691-708, doi:10.1038/s43587-024-00799-6
  • Khawaja,RR;Griego,E;Lindenau,K;Salek,A;Gambardella,J;Scrivo,A;Monday,HR et al, Chaperone-mediated autophagy regulates neuronal activity by sex-specific remodelling of the synaptic proteome, Nat Cell Biol, 2025;27(10):1688-1707, doi:10.1038/s41556-025-01771-1
  • Blasco Agell,L;Pons Espinal,M;Testa,V;Roch,G;Montero Munoz,J;Fernandez Carasa,I;Baruffi,V et al, LRRK2-mutant microglia and neuromelanin synergize to drive dopaminergic neurodegeneration in an iPSC-based Parkinson’s disease model, Commun Biol, 2025;8(1):1203-1203, doi:10.1038/s42003-025-08544-4
PROJECTS

2 Ongoing competive projects
1 Ongoing non competive project

INNOVATION

1 Patent

PUBLISHED WORKS

1 Thesis

NETWORKS

SGR GRC-2021

Selected projects

  • 2022 BP 00242. 2022 BP 00242 -SCRIVO. AGENCIA GESTIO D’AJUTS UNIV. I RECERCA. Budget: 270.700 €. 2024-2027. PI: CONSIGLIO, ANTONELLA.
  • CI24-20499. NeurAntigen: A human Neural Method for the Diagnosis of Autoimmune Encephalites. FUNDACIÓ “LA CAIXA”. Budget: 76.835€. 2024-2026. PI: CONSIGLIO, ANTONELLA.
  • Assessing the ability of “INDENA’s Colchine to prevent a-synuclein accumulation in a human iPSC-derived Parkinson’s disease. INDENA S.L. Budget: 40.000€. 2021- . PI: ANTONELLA CONSIGLIO.